CN Patent

CN116410195B — 一种己二酸盐结晶及其制备方法

Assigned to Tongrun Biomedical Shanghai Co ltd · Expires 2025-07-18 · 1y expired

What this patent protects

本发明涉及一种PI3Kδ/γ双重抑制剂化合物(S)‑2‑(1‑(9H‑嘌呤‑6‑基氨基)丙基)‑3‑(3‑氟苯基)‑4H‑色烯‑4‑酮化合物的己二酸盐结晶及其制备方法。本发明的结晶在物理性质和药效/药代动力学方面更优异。

USPTO Abstract

本发明涉及一种PI3Kδ/γ双重抑制剂化合物(S)‑2‑(1‑(9H‑嘌呤‑6‑基氨基)丙基)‑3‑(3‑氟苯基)‑4H‑色烯‑4‑酮化合物的己二酸盐结晶及其制备方法。本发明的结晶在物理性质和药效/药代动力学方面更优异。

Drugs covered by this patent

Patent Metadata

Patent number: CN116410195B
Jurisdiction: CN
Classification: —
Expires: 2025-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Tongrun Biomedical Shanghai Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.